Fariba Goodarzian - Concepedia

Author

Fariba Goodarzian

Machine Intelligence Research Labs ORCID

Also Known As

F Goodarzian, F. Goodarzian, Fariba Goodarzian, Goodarzian, F.

150

Publications

4.1K

Citations

H-Index

120

Concepts

All Affiliations

Machine Intelligence Research Labs Children's Hospital of Los Angeles Universidad de Sevilla University of Southern California Yazd University

About

Fariba Goodarzian is an author at Machine Intelligence Research Labs specializing in engineering, logistics, and systems engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	25	32	1.7K
2	Business	24	31	1.6K
3	Medicine	6	6	310
4	Health Sciences	2	2	125
5	Nursing	2	2	233

Fariba Goodarzian

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Designing a sustainable closed-loop supply chain network of face masks during the COVID-19 pandemic: Pareto-based algorithms Erfan Babaee Tırkolaee, Alireza Goli, Peiman Ghasemi, Journal of Cleaner Production Face MasksGlobal HealthCovid-19 PandemicPareto-based AlgorithmsCovid-19	2021	240
An integrated sustainable medical supply chain network during COVID-19 Fariba Goodarzian, Ata Allah Taleizadeh, Peiman Ghasemi, Engineering Applications of Artificial Intelligence Healthcare Supply Chain ManagementGlobal Health CrisisCovid-19 PandemicBusinessHealth Supply Chain	2021	227
A bi-objective home healthcare routing and scheduling problem considering patients’ satisfaction in a fuzzy environment Amir M. Fathollahi‐Fard, Abbas Ahmadi, Fariba Goodarzian, Applied Soft Computing NursingFamily MedicinePatients ’ SatisfactionFuzzy LogicEngineering	2020	167
A multi-objective pharmaceutical supply chain network based on a robust fuzzy model: A comparison of meta-heuristics Fariba Goodarzian, Hasan Hosseini-Nasab, Jesús Muñuzuri, Applied Soft Computing Fuzzy Multi-criteria Decision-makingRobust Fuzzy ModelSupply Chain OptimizationFuzzy LogicEngineering	2020	159
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial Steven G. DuBois, Araz Marachelian, Elizabeth Fox, Journal of Clinical Oncology	2016	132
A sustainable-resilience healthcare network for handling COVID-19 pandemic Fariba Goodarzian, Peiman Ghasemi, Angappa Gunasekaren, Annals of Operations Research Covid-19Global Health CrisisCovid-19 PandemicSustainable-resilience Healthcare NetworkPublic Health	2021	112
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Nature Medicine	2023	112
Designing an integrated responsive-green-cold vaccine supply chain network using Internet-of-Things: artificial intelligence-based solutions Fariba Goodarzian, Ali Navaei, Behdad Ehsani, Annals of Operations Research Artificial IntelligenceVaccinationArtificial Intelligence-based SolutionsEngineeringIntelligent Network	2022	107
Changes in Brown Adipose Tissue in Boys and Girls during Childhood and Puberty Vicente Gilsanz, Michelle L. Smith, Fariba Goodarzian, The Journal of Pediatrics ObesityChildhood ObesityBody CompositionAdipose TissuePhysiology	2011	97
131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study Gregory A. Yanik, Judith G. Villablanca, John M. Maris, Biology of Blood and Marrow Transplantation	2015	93

Page 1